Elacytarabine (CP-4055) in the treatment of acute myeloid leukemia

Author： DiNardo Courtney D O'Brien Susan Gandhi Varsha V Ravandi Farhad

ISSN： 1479-6694

Source： Future Oncology, Vol.9, Iss.8, 2013-08, pp. : 1073-1082

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clofarabine for the treatment of adult acute myeloid leukemia

By Thomas Xavier Raffoux Emmanuel Elhamri Mohamed Lobe Ida Cannas Giovanna Dombret Hervéé

Future Oncology, Vol. 5, Iss. 8, 2009-10 ,pp. : 1197-1210

Future Medicine

Access to resources Recommend Favorite

Treatment of acute myeloid leukemia with hematopoietic stem cell transplantation

By Jones Cortney V Copelan Edward A

Future Oncology, Vol. 5, Iss. 4, 2009-05 ,pp. : 559-568

Future Medicine

Access to resources Recommend Favorite

Clinical study of Mito-FLAG regimen in treatment of relapsed acute myeloid leukemia

Experimental and Therapeutic Medicine, Vol. 5, Iss. 3, 2013-01 ,pp. : 982-986

Spandidos Publications

Access to resources Recommend Favorite

Development of treatment and clinical results in childhood acute myeloid leukemia in Slovenia in the period from 1991 to 2010

By Velikonja Orjana Stefanović Milica Kitanovski Lidija Podgornik Helena Jazbec Janez

memo - Magazine of European Medical Oncology, Vol. 7, Iss. 1, 2014-02 ,pp. : 56-62

Springer Publishing Company

Access to resources Recommend Favorite

Histamine dihydrochloride for the treatment of acute myeloid leukemia, malignant melanoma and renal cell carcinoma

By Perz Jolanta B Ho Anthony D

Future Oncology, Vol. 4, Iss. 2, 2008-04 ,pp. : 169-177

Future Medicine

Access to resources Recommend Favorite